These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6976522)

  • 1. Antagonism by methysergide of the effects of L-5-hydroxytryptophan and quipazine on schedule-controlled responding.
    Leander JD
    Neuropharmacology; 1981 Dec; 20(12A):1141-3. PubMed ID: 6976522
    [No Abstract]   [Full Text] [Related]  

  • 2. Antagonism by ketanserin of the behavioral effects of quipazine but not l-5-hydroxytryptophan in squirrel monkeys.
    Witkin JM; Brady LS; Barrett JE
    Psychopharmacology (Berl); 1988; 94(3):302-5. PubMed ID: 3128804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonism of the behavioral effects of 2,5-dimethoxy-4-methylamphetamine (DOM) and quipazine by metergoline.
    Commissaris RL; Rech RH
    Pharmacol Biochem Behav; 1981 Oct; 15(4):659-62. PubMed ID: 7291270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clozapine blocks disruptive and discriminative stimulus effects of quipazine.
    Friedman RL; Sanders-Bush E; Barrett RL
    Eur J Pharmacol; 1984 Oct; 106(1):191-3. PubMed ID: 6529966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methysergide blocks the sleep suppressant action of quipazine in rats.
    Fornal C; Radulovacki M
    Psychopharmacology (Berl); 1982; 76(3):255-9. PubMed ID: 6808546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of quipazine on behavior under a multiple schedule of reinforcement.
    Poling A; Appel JB
    Pharmacol Biochem Behav; 1978 Apr; 8(4):491-2. PubMed ID: 674254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of quipazine and methysergide on play in juvenile rats.
    Normansell L; Panksepp J
    Pharmacol Biochem Behav; 1985 May; 22(5):885-7. PubMed ID: 2989950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of serotonin agonists on operant behavior in the squirrel monkey: quipazine, MK-212, trifluoromethylphenylpiperazine, and chlorophenylpiperazine.
    McKearney JW
    Pharmacol Biochem Behav; 1990 Jan; 35(1):181-5. PubMed ID: 2315357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metoclopramide antagonism of 5-hydroxytryptophan-induced "wet-dog" shake behaviour in the rat.
    Fozard JR; Palfreyman MG
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Jun; 307(2):135-42. PubMed ID: 314597
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of serotonin receptor agonists and antagonists on schedule-controlled behavior of squirrel monkeys.
    Brady LS; Barrett JE
    J Pharmacol Exp Ther; 1985 Nov; 235(2):436-41. PubMed ID: 2932546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agonist and antagonist properties of serotonergic compounds in pigeons trained to discriminate either quipazine or L-5-hydroxytryptophan.
    Yamamoto T; Walker EA; Woods JH
    J Pharmacol Exp Ther; 1991 Sep; 258(3):999-1007. PubMed ID: 1890629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quipazine-induced head-twitch in mice.
    Malick JB; Doren E; Barnett A
    Pharmacol Biochem Behav; 1977 Mar; 6(3):325-9. PubMed ID: 140381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The acute effects of 5HTP, fluoxetine and quipazine on insulin and glucagon release in the intact rat.
    Jacoby JH; Bryce GF
    Horm Metab Res; 1979 Feb; 11(2):90-4. PubMed ID: 312241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the behavioral effects of para-chloroamphetamine, chlordimeform, quipazine, and intraventricular serotonin in the rat.
    Pfister WR; Noland V; Lowy MT; Nichols DE; Yim GK
    Commun Psychopharmacol; 1978; 2(4):287-95. PubMed ID: 729354
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of head twitch response to quipazine in rats by chronic amitriptyline but not fluvoxamine or citalopram.
    Pawłowski L; Melzacka M
    Psychopharmacology (Berl); 1986; 88(3):279-84. PubMed ID: 3083448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic activity of quipazine.
    Schechter MD; Concannon JT
    Pharmacol Biochem Behav; 1982 Sep; 17(3):393-7. PubMed ID: 7146043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of salbutamol upon performance on an operant screen for antidepressants.
    Dunn RT; Richards JB; Seiden LS
    Psychopharmacology (Berl); 1993; 113(1):1-10. PubMed ID: 7862813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of the behavioral effects of lysergic acid diethylamide, 2,5-dimethoxy-4-methylamphetamine, quipazine and lisuride by 5-hydroxytryptamine antagonists.
    Mokler DJ; Commissaris RL; Warner MR; Rech RH
    J Pharmacol Exp Ther; 1983 Dec; 227(3):557-62. PubMed ID: 6655557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of quipazine and fluoxetine on extinction of a previously-reinforced operant response in rats.
    Beninger RJ
    Pharmacol Biochem Behav; 1984 Oct; 21(4):533-7. PubMed ID: 6334317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of d-amphetamine and ethanol alone and in combination on schedule-controlled responding of pigeons.
    Katz JL; Barrett JE
    Psychopharmacology (Berl); 1979 Jun; 64(1):13-8. PubMed ID: 113825
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.